Start of commercial production in Pomacle
24 Mars 2022 - 5:48PM
Start of commercial production
in Pomacle
First batches manufactured in March
2022
Commercial launch at In-Cosmetics in
Paris
Scale-up trajectory
accelerated
Paris, 24 March 2022 –
Global Bioenergies announces the start of production at
its Pomacle
unit. Pomacle
is at the heart of a new and fully French
renewable isododecane production
chain. Its commercial launch will take place under the
“Isonaturane® 12”
brand at In-Cosmetics in Paris in early April. The Company is
accelerating its scale-up trajectory and reaffirming its ambitions
in aviation biofuels.
Start of commercial production
in Pomacle
The Company’s first commercial unit, located on
the ARD site in Pomacle-Bazancourt, near Reims, has begun
production on schedule. The first batches of biosourced isobutene
have been manufactured at this unit in March 2022.
This new and fully French production chain,
using raw materials sourced locally, was established thanks to
developments in the manufacturing process, which now relies on
subcontractors both upstream (industrial fermentation) and
downstream (green chemistry).
Participation in the In-Cosmetics trade
show
To promote this emerging sector, Global
Bioenergies is to exhibit its flagship ingredient at In-Cosmetics
from 5 to 7 April. In-Cosmetics is the world’s leading trade show
for cosmetic ingredients. Isonaturane® 12
will be marketed to the big names in cosmetics and major
manufacturers in the field.
Daphne Galvez, Global Bioenergies Head of Sales,
said: “In-Cosmetics is a great place to showcase innovations and
the ideal venue to launch a new ingredient on the market. It will
represent a new milestone for Global Bioenergies:
Isonaturane® 12 has cleared all the
regulatory hurdles. It has been validated at market scale with our
LAST® make-up brand, the first in the world to
combine longwear, waterproof and no transfer properties with
natural origin. Our aim is now to distribute this innovative
ingredient to players in the field, in order to help them convert
their make-up ranges to naturalness without any compromise on
performance. The start-up of the new unit will enable us to respond
to sampling requests from numerous prospects, and complete
referencing procedures prior to the commercial delivery of material
in the second half of 2022.”
Accelerated scale-up
prospects
The success of the unit’s start-up without any
major difficulties means that the scale-up schedule can be
accelerated: the Company now expects to reach full capacity by the
end of 2022, rather than over 18 months as initially projected.
That will take the unit’s isobutene annual production capacity to
100 tonnes. The isobutene will then be converted into isododecane
for the make-up ingredients market.
The scale-up to 1,000 tonnes, planned for late
2024 or early 2025, is starting to look like a realistic prospect.
The aim will be to target the broader dermo-cosmetics and hair care
markets. That will put Global Bioenergies in a strong position to
target the much larger aviation biofuels market by 2026 or 2027.
Using the ingredient in this sector will bring a significant
environmental impact (CO2 reductions), while at the same time
helping reduce Europe’s energy dependency.
Marc Delcourt, Chief Executive Officer of Global
Bioenergies, said: “The fight against global warming and the quest
to achieve Europe’s strategic challenges have become central
concerns across the board, and remind us of the relevance of the
Company’s strategy and investments since its creation in 2008. Our
target markets, cosmetic ingredients in the short term and aviation
biofuels in the medium term, are booming: the number of potential
customers is increasing rapidly, as are the potential competitors
for our Company. We can now state that our process, patiently
developed over more than 10 years, is unique and offers specific
and decisive advantages that will enable us to compete in the
cosmetic ingredients market. In the aviation biofuels market, it
will be necessary to improve performance further, but we believe
that to be achievable within 12 to 24 months. We will then
boast the best fermentation process in the world to decarbonise air
transport.”
About GLOBAL BIOENERGIES
Global Bioenergies has developed a process to
convert plant-derived resources into a family of compounds used in
the cosmetics industry as well as the energy and materials sectors.
In 2021, the Group entered the market with the launch of LAST®, its
own make-up brand with formulas based on a key ingredient produced
via its technology. The Company is constantly seeking to enhance
the performance of its process while gradually ramping up
production capacities in order to supply ingredients to major
cosmetics manufacturers, thereby promoting naturalness in the
industry whilst improving its carbon footprint. Some of these
compounds can also be used to produce renewable plastics, rubbers
and paints. Lastly, Global Bioenergies is also aiming to
reduce CO2 emissions in the aviation sector and thereby curb global
warming. Global Bioenergies is listed on Euronext Growth Paris
(FR0011052257 – ALGBE).
Receive information about Global
Bioenergies directly by subscribing to our news feed on
www.global-bioenergies.com
Follow us on Twitter:
@GlobalBioenergi
Contacts
GLOBAL BIOENERGIESLet’s meet at In-Cosmetics:Stand
S40Daphne GalvezHead of SalesPhone: 33 7 87 04 51
03BOOK A
MEETING invest@global-bioenergies.com |
PRESS RELATIONS Iva
Baytchevaibaytcheva@ulysse-communication.com Nicolas
Danielsndaniels@ulysse-communication.com |
- Global Bioenergies - Start of commercial production in Pomacle
and participation in the In-Cosmetics trade show
Global Bioenergies (EU:ALGBE)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Global Bioenergies (EU:ALGBE)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024